NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 12, 2021 Bullish $127.82 X 0
JS JS Pro
Apr 5, 2021 $189.08 +6.65% $177.29 X 93.35% 0
geordiecrew77 geordiecrew77 Amateur
Apr 5, 2021 $186.80 +5.36% $177.29 X 94.64% 0
geordiecrew77 geordiecrew77 Amateur
Apr 1, 2021 $183.00 -1.52% $185.82 X 98.48% 1
geordiecrew77 geordiecrew77 Amateur
Mar 31, 2021 $177.00 -2.38% $181.31 X 97.62% 1
JS JS Pro
Mar 31, 2021 $177.57 -2.06% $181.31 X 97.94% 1
JS JS Pro
Mar 29, 2021 $188.15 +8.29% $173.75 X 91.71% 0
geordiecrew77 geordiecrew77 Amateur
Mar 29, 2021 $183.50 +5.61% $173.75 X 94.39% 0
JS JS Pro
Mar 26, 2021 $169.64 -6.85% $182.12 X 93.15% 0
geordiecrew77 geordiecrew77 Amateur
Mar 26, 2021 $205.00 +12.56% $182.12 X 87.44% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE